Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2001 1
2002 3
2003 8
2004 3
2005 3
2006 5
2007 1
2010 2
2011 2
2013 2
2014 5
2015 1
2016 3
2017 5
2018 3
2019 1
2020 1
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for massacesi c
Search for Massacessi C instead (1 results)
Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Slamon D, et al. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
Soria JC, Tan DSW, Chiari R, Wu YL, Paz-Ares L, Wolf J, Geater SL, Orlov S, Cortinovis D, Yu CJ, Hochmair M, Cortot AB, Tsai CM, Moro-Sibilot D, Campelo RG, McCulloch T, Sen P, Dugan M, Pantano S, Branle F, Massacesi C, de Castro G Jr. Soria JC, et al. Among authors: massacesi c. Lancet. 2017 Mar 4;389(10072):917-929. doi: 10.1016/S0140-6736(17)30123-X. Epub 2017 Jan 24. Lancet. 2017. PMID: 28126333 Clinical Trial.
Curative-Intent Treatment with Durvalumab in Early-Stage Cancers.
Melillo G, Chand V, Yovine A, Gupta A, Massacesi C. Melillo G, et al. Among authors: massacesi c. Adv Ther. 2021 Jun;38(6):2759-2778. doi: 10.1007/s12325-021-01675-0. Epub 2021 Apr 21. Adv Ther. 2021. PMID: 33881745 Free PMC article. Review.
Diversity of US participants in AstraZeneca-sponsored clinical trials.
Cabrera C, Fernández-Llaneza D, Ghazoui Z, D'Abrantes S, Esparza-Franco MA, Sopp C, Maj B, Chiou VL, Valastro B, Pangalos MN, Galbraith S, Ghiorghiu S, Massacesi C. Cabrera C, et al. Among authors: massacesi c. Contemp Clin Trials. 2024 May;140:107496. doi: 10.1016/j.cct.2024.107496. Epub 2024 Mar 11. Contemp Clin Trials. 2024. PMID: 38467274 Free article.
Challenges in the clinical development of PI3K inhibitors.
Massacesi C, di Tomaso E, Fretault N, Hirawat S. Massacesi C, et al. Ann N Y Acad Sci. 2013 Mar;1280(1):19-23. doi: 10.1111/nyas.12060. Ann N Y Acad Sci. 2013. PMID: 23551097 Free PMC article. Review.
52 results